Investing carries serious risks, including partial or total loss of capital. Please read the Information Note and the Risk factors and login before investing.

OLYS Pharma® 1A

Equity
254,000 €
total amount raised
3 days
remaining
  • Backed by over 100 investors

Philippe Van Wesepoel

Co-founder

Jean François Plucker

Co-founder

TAX SHELTER 45%

The available budget for Tax Shelter investments has been fully utilised. Investments will not be eligible for the tax shelter advantage.

Raise summary

Crowd investments 229,000 €
Committed by others 25,000 €
Amount raised 254,000 €
Minimum round 75,000 €
Maximum round 500,000 €
Equity offered 23.073%
Pre-money valuation 1,667,000 €
Post-money valuation min. 1,742,000 €
Post-money valuation max. 2,167,000 €